Albuterol Use During Pregnancy

Safety and Efficacy

Inadequate control of asthma poses a greater risk to the fetus than asthma medications, including albuterol, as uncontrolled asthma can lead to decreased oxygen supply to the fetus, potentially causing serious complications 1, 2
Albuterol is the preferred short-acting beta-agonist (SABA) during pregnancy because it has the most safety data available compared to other SABAs 3

Despite the FDA Pregnancy Category C classification, clinical experience and guideline recommendations from the American College of Allergy, Asthma, and Immunology support albuterol as the first-choice SABA during pregnancy 3, 4

For quick relief of asthma symptoms during pregnancy, 2-4 puffs of albuterol via metered-dose inhaler (MDI) as needed is recommended 5
For nebulizer treatment, the standard adult dose is 2.5 mg every 20 minutes for 3 doses, then every 1-4 hours as needed 2, 6

Monthly evaluations of asthma control and pulmonary function are recommended during pregnancy, as asthma symptoms may change 3
The goal of asthma treatment during pregnancy is to maintain control with minimal or no chronic symptoms, no exacerbations, no activity limitations, near-normal pulmonary function, and minimal use of rescue medications 1, 2

Excessive use of albuterol should be avoided as systemic administration may cause cardiovascular and metabolic adverse effects 4

For pregnant women with asthma, maintaining proper control of asthma should be the priority, as this enables a normal pregnancy with little or no risk to mother or fetus 1, 2
If a pregnant woman requires frequent use of albuterol (more than twice weekly), this indicates inadequate control and the need to initiate or increase long-term control therapy 5
For moderate to severe asthma during pregnancy, albuterol should be used alongside appropriate controller medications such as inhaled corticosteroids (preferably budesonide) 3